Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pharmacotherapy

Treating congenital hypothyroidism—which levothyroxine?

Biochemical screening of neonates for congenital hypothyroidism permits early initiation of levothyroxine treatment and thus prevents the development of intellectual disability. Two novel studies now address whether brand-name and generic levothyroxine are interchangeable in this context.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Grosse, S. D. & Van Vliet, G. Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level? Arch. Dis. Child. 96, 374–379 (2011).

    Article  Google Scholar 

  2. Dong, B. J. et al. Bioequivalence of generic and brand-name levothyroxine products in the treatment of hypothyroidism. JAMA 277, 1205–1213 (1997).

    Article  CAS  Google Scholar 

  3. Blakesley, V. et al. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid 14, 191–200 (2004).

    Article  CAS  Google Scholar 

  4. Carswell, J. M., Gordon, J. H., Popovsky, E., Hale, A. & Brown, R. S. Generic and brand-name L-thyroxine are not bioequivalent for children with severe congenital hypothyroidism. J. Clin. Endocrinol. Metab. 98, 610–617 (2013).

    Article  CAS  Google Scholar 

  5. Lomenick, J. P., Wang, L., Ampah, S. B., Saville, B. R. & Greenwald, F. I. Generic levothyroxine compared with synthroid in young children with congenital hypothyroidism. J. Clin. Endocrinol. Metab. 98, 653–658 (2013).

    Article  CAS  Google Scholar 

  6. Fruzza, A. G., Demeterco-Berggren, C. & Jones, K. L. Unawareness of the effects of soy intake on the management of congenital hypothyroidism. Pediatrics 130, e699–e702 (2012).

    Article  Google Scholar 

  7. Balapatabendi, M., Harris, D. & Shenoy, S. D. Drug interaction of levothyroxine with infant colic drops. Arch. Dis. Child. 96, 888–889 (2011).

    Article  Google Scholar 

  8. Selva, K. A., Harper, A., Downs, A., Blasco, P. A. & Lafranchi, S. H. Neurodevelopmental outcomes in congenital hypothyroidism: comparison of initial T4 dose and time to reach target T4 and TSH. J. Pediatr. 147, 775–780 (2005).

    Article  CAS  Google Scholar 

  9. Simoneau-Roy, J. et al. Cognition and behavior at school entry in children with congenital hypothyroidism treated early with high-dose levothyroxine. J. Pediatr. 144, 747–752 (2004).

    Article  CAS  Google Scholar 

  10. Cassio, A. et al. Comparison between liquid and tablet formulations of levothyroxine in the initial treatment of congenital hypothyroidism. J. Pediatr. http://dx.doi.org/10.1016/j.jpeds.2012.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guy Van Vliet.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deladoëy, J., Van Vliet, G. Treating congenital hypothyroidism—which levothyroxine?. Nat Rev Endocrinol 9, 257–258 (2013). https://doi.org/10.1038/nrendo.2013.46

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2013.46

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing